Filters

59 Results

relevance


Excedrin Migraine Pain Relief

Ad Alert

Excedrin Migraine Pain Relief

A reader submitted a tip concerning the pricing of Excedrin Migraine Pain Reliever versus Excedrin Extra Strength Pain Reliever.

LASIK Providers Unclear on Risks

Ad Alert

LASIK Providers Unclear on Risks

The FDA sent warning letters to four LASIK providers for promoting the procedure on their websites without adequate warning about the risks involved.

Fungus Eliminator

Ad Alert

Fungus Eliminator

Forty-five million Americans are ‘fighting a losing battle’ against toenail fungus. Could this supplement be the solution?

Mundo Natural Products

Ad Alert

Mundo Natural Products

FDA has sent a warning letter to Mundo Natural Inc. for selling several of its products in violation of FDA regulations. According to the FDA’s letter sent in April, the…

MegaGraviola

Ad Alert

MegaGraviola

The FDA has sent a warning letter to M&A Caribbean Traders, Inc. for selling MegaGraviola in violation of FDA regulations. According to the FDA’s letter sent in April 2014, the…

Graviola Extract

Ad Alert

Graviola Extract

The FDA sent a warning letter to Graviola Group in April 2014 for selling its Graviola Extract without FDA approval in violation of the FDA regulations. According to the FDA’s…

SmartPractice

Ad Alert

SmartPractice

According to a warning letter from the FDA, the Danish company, SmartPractice, promoted an allergic contact dermatitis test kit called T.R.U.E. Test® without adequate potential risk information, including that the product…

JustAnswer

Ad Alert

JustAnswer

Cost to ask a question and actually have it answered remains elusive for consumers.

TruHeight

Ad Alert

TruHeight

Company marketing “height growth vitamins” makes some tall claims.

InvestorPlace

Ad Alert

InvestorPlace

Consumers looking to increase their wealth may need to look elsewhere.

Show More